Induced myeloperoxidase activity and related superoxide inhibition during hormone replacement therapy
- 1 May 2001
- journal article
- clinical trial
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 108 (5) , 474-481
- https://doi.org/10.1111/j.1471-0528.2001.00108.x
Abstract
To test whether the menopause entails any changes in the myeloperoxidase activity of neutrophil granulocytes. The effects of hormone replacement therapy on myeloperoxidase activity and related changes in free radical production were also investigated. Laboratory investigation of the effect of oestrogen on intracellular myeloperoxidase activity and release from human neutrophil granulocytes. Analysis of related changes in superoxide anion generation. 2nd Department of Medicine and 1st Department of Obstetrics and Gynaecology, Semmelweis University, Budapest. Intracellular myeloperoxidase activity (mean peroxidase index) was measured automatically in blood samples obtained for general laboratory work-up from 135 randomly selected patients in our department. Blood samples from 11 postmenopausal women were analysed before and during hormone replacement therapy. Blood samples from 20 healthy volunteers were obtained and neutrophil granulocytes separated for in vitro measurement of superoxide anion production after adding myeloperoxidase to the incubation media. The mean peroxidase index was measured using a Technicon H-3 instrument. myeloperoxidase release from neutrophils was quantified by ELISA technique. Superoxide production of isolated neutrophil granulocytes was measured by photometry. Intracellular activity of myeloperoxidase, concentration of myeloperoxidase-protein in supernatant of neutrophils, release of superoxide anion from neutrophil granulocytes. 1. Intracellular myeloperoxidase activity in neutrophils was lower in postmenopausal women, than in females with regular cycles (-1.84 +/- 3.06 versus 1.59 +/- 3.55, P < 0,001). 2. In postmenopausal women intracellular myeloperoxidase activity and myeloperoxidase release increased during hormone replacement therapy (-5.54 +/- 6.63 versus -0.2 +/- 6.05; P < 0.001 and 52.74 mU/ml +/- 25.73 versus 251.4 +/-234.1 mU/ml; P < 0.05). 3. Adding myeloperoxidase to neutrophil granulocyte suspensions, the production of superoxide anion fell (e.g. adding 280 ng/ml myeloperoxidase: 77.9 +/- 14.04 % of control production, P < 0.001). Hormone replacement restores the reduced myeloperoxidase activity in menopausal women. Adding myeloperoxidase to neutrophil granulocytes, the production of free radicals decreases.Keywords
This publication has 27 references indexed in Scilit:
- Phagocytes and oxidative stressPublished by Elsevier ,2004
- Myeloperoxidase-generated oxidants and atherosclerosisFree Radical Biology & Medicine, 2000
- Stereoisomer-Specific Inhibition of Superoxide Anion-Induced Rat Aortic Smooth-Muscle Cell Proliferation by 17β-Estradiol is Estrogen Receptor DependentJournal of Cardiovascular Pharmacology, 1998
- The Biology of Estrogen-Mediated Repair of Cardiovascular InjuryThe Annals of Thoracic Surgery, 1998
- Leukocyte activation in atherosclerosis: correlation with risk factorsAtherosclerosis, 1997
- Can free radicals induce coronary vasospasm and acute myocardial infarction?Medical Hypotheses, 1992
- Reduced oxidative activity of circulating neutrophils in patients after myocardial infarctionCell Biochemistry and Function, 1990
- Menopause and Risk Factors for Coronary Heart DiseaseNew England Journal of Medicine, 1989
- CORTICOSTEROID (METHYLPREDNISOLONE) MODULATION OF PHOTOPEROXIDATION BY ULTRAVIOLET LIGHT IN LIPOSOMESPhotochemistry and Photobiology, 1979
- Polymorphonuclear Leucocyte Function during PregnancyScandinavian Journal of Immunology, 1978